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We thank Drs Shibata-Hiraizumi and Suzuki 1 for their interest and informative comments on our recent article involving maternal ABO blood group and adverse pregnancy outcomes. 2 It was not our intention to include intrauterine fetal death as one of the outcomes because including both stillbirths and live births would constitute a heterogeneous population. This might influence the other outcomes. Furthermore, we were aware of the multifactorial etiology of intrauterine fetal death, for example, obstetric conditions, placental abnormalities, fetal genetic/structural abnormalities, infection, umbilical cord abnormalities, hypertensive disorders, unexplained cause, etc. 
